BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23280833)

  • 1. Repolarization matters: mutations in the Kv4.3 potassium channel cause SCA19/22.
    Pulst SM; Otis TS
    Ann Neurol; 2012 Dec; 72(6):829-31. PubMed ID: 23280833
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.
    Duarri A; Jezierska J; Fokkens M; Meijer M; Schelhaas HJ; den Dunnen WF; van Dijk F; Verschuuren-Bemelmans C; Hageman G; van de Vlies P; Küsters B; van de Warrenburg BP; Kremer B; Wijmenga C; Sinke RJ; Swertz MA; Kampinga HH; Boddeke E; Verbeek DS
    Ann Neurol; 2012 Dec; 72(6):870-80. PubMed ID: 23280838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
    Duarri A; Lin MC; Fokkens MR; Meijer M; Smeets CJ; Nibbeling EA; Boddeke E; Sinke RJ; Kampinga HH; Papazian DM; Verbeek DS
    Cell Mol Life Sci; 2015 Sep; 72(17):3387-99. PubMed ID: 25854634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in KCND3 cause spinocerebellar ataxia type 22.
    Lee YC; Durr A; Majczenko K; Huang YH; Liu YC; Lien CC; Tsai PC; Ichikawa Y; Goto J; Monin ML; Li JZ; Chung MY; Mundwiller E; Shakkottai V; Liu TT; Tesson C; Lu YC; Brice A; Tsuji S; Burmeister M; Stevanin G; Soong BW
    Ann Neurol; 2012 Dec; 72(6):859-69. PubMed ID: 23280837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel SCA19/22-associated KCND3 mutations disrupt human K
    Hsiao CT; Fu SJ; Liu YT; Lu YH; Zhong CY; Tang CY; Soong BW; Jeng CJ
    Hum Mutat; 2019 Nov; 40(11):2088-2107. PubMed ID: 31293010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19.
    Paucar M; Bergendal Å; Gustavsson P; Nordenskjöld M; Laffita-Mesa J; Savitcheva I; Svenningsson P
    Cerebellum; 2018 Aug; 17(4):465-476. PubMed ID: 29527639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An E280K Missense Variant in
    Ågren R; Geerdink N; Brunner HG; Paucar M; Kamsteeg EJ; Sahlholm K
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel
    Zanni G; Hsiao CT; Fu SJ; Tang CY; Capuano A; Bosco L; Graziola F; Bellacchio E; Servidei S; Primiano G; Soong BW; Jeng CJ
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067185
    [No Abstract]   [Full Text] [Related]  

  • 9. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.
    Smets K; Duarri A; Deconinck T; Ceulemans B; van de Warrenburg BP; Züchner S; Gonzalez MA; Schüle R; Synofzik M; Van der Aa N; De Jonghe P; Verbeek DS; Baets J
    BMC Med Genet; 2015 Jul; 16():51. PubMed ID: 26189493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy.
    Singh B; Ogiwara I; Kaneda M; Tokonami N; Mazaki E; Baba K; Matsuda K; Inoue Y; Yamakawa K
    Neurobiol Dis; 2006 Nov; 24(2):245-53. PubMed ID: 16934482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism in SCA19/22: Dopamine Transporter Imaging in an Italian Family Harboring a Novel Mutation.
    Contaldi E; Gallo S; Corrado L; D'Alfonso S; Magistrelli L
    Cerebellum; 2024 Jun; 23(3):1226-1230. PubMed ID: 37857779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.
    You T; Mao W; Cai B; Li F; Xu H
    Int J Mol Med; 2015 Jul; 36(1):309-15. PubMed ID: 26016905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation.
    Olesen MS; Refsgaard L; Holst AG; Larsen AP; Grubb S; Haunsø S; Svendsen JH; Olesen SP; Schmitt N; Calloe K
    Cardiovasc Res; 2013 Jun; 98(3):488-95. PubMed ID: 23400760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric and adult recessive ataxias (update 6).
    Morrison PJ
    Eur J Paediatr Neurol; 2010 May; 14(3):264-6. PubMed ID: 19910227
    [No Abstract]   [Full Text] [Related]  

  • 15. KCND3 mutations in Brugada syndrome: the plot thickens.
    van den Berg MP; Bezzina CR
    Heart Rhythm; 2011 Jul; 8(7):1033-5. PubMed ID: 21640846
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of human cardiac potassium channels by full-length KCNE3 and KCNE4.
    Abbott GW
    Sci Rep; 2016 Dec; 6():38412. PubMed ID: 27922120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNE3 is an inhibitory subunit of the Kv4.3 potassium channel.
    Lundby A; Olesen SP
    Biochem Biophys Res Commun; 2006 Aug; 346(3):958-67. PubMed ID: 16782062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary for "oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8".
    Frucht S
    Mov Disord; 2012 Dec; 27(14):1743. PubMed ID: 23283654
    [No Abstract]   [Full Text] [Related]  

  • 19. Episodic ataxia type 2. Three novel truncating mutations and one novel missense mutation in the CACNA1A gene.
    van den Maagdenberg AM; Kors EE; Brunt ER; van Paesschen W; Pascual J; Ravine D; Keeling S; Vanmolkot KR; Vermeulen FL; Terwindt GM; Haan J; Frants RR; Ferrari MD
    J Neurol; 2002 Nov; 249(11):1515-9. PubMed ID: 12420090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PEX10 are a cause of autosomal recessive ataxia.
    Régal L; Ebberink MS; Goemans N; Wanders RJ; De Meirleir L; Jaeken J; Schrooten M; Van Coster R; Waterham HR
    Ann Neurol; 2010 Aug; 68(2):259-63. PubMed ID: 20695019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.